Co-occurrence of DNMT3A, NPM1, FLT3 mutations identifies a subset of acute myeloid leukemia with adverse prognosis. (2020)
Attributed to:
Epigenomic Mechanisms of Action of Novel Mutant Isocitrate Dehydrogenase Inhibitors in Acute Myeloid Leukaemia
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1182/blood.2019003339
PubMed Identifier: 31977039
Publication URI: http://europepmc.org/abstract/MED/31977039
Type: Journal Article/Review
Volume: 135
Parent Publication: Blood
Issue: 11
ISSN: 0006-4971